Myriad Genetics, Inc.: Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and tumor genomic testing and precision medicine, announced that the United States Patent and ...
Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test
SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc.
Myriad Genetics, INTERLINK Partner To Enhance Access To Hereditary Cancer Testing
Myriad Genetics, Inc. (MYGN), a genetic and genomic tumor testing and precision medicine provider, and INTERLINK Care Management, ...
The Forward on MSN7h
How one Jewish geneticist turned a family tragedy into a lifesaving mission.
February is American Heart Month, which is an appropriate time to learn how genetic testing can protect your family.
KJZZ7h
A biotech company will pay tribes for genetic data. This professor hopes it could change the industry
Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...
Scientific American11h
Who Discovered the Cause of Down Syndrome?
It took more than 50 years for Marthe Gautier to set the record straight about her discovery of the genetic cause of Down ...